Pelthos Therapeutics Inc.
PTHSNYSEAMERICANHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $60.17M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $18.19$37.50
- Volume (live)
- -
- Avg. volume (3M)
- 46.69K
Pelthos Therapeutics (PTHS) Stock Price & Financial Analysis
Pelthos Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $17.50 - $19.49 |
|---|---|
| 52-Week High | $37.50 |
| 52-Week Low | $18.19 |
| Open | $19.49 |
| Volume (last close) | 57.78K |
| Average Volume (3M) | 46.69K |
| Revenue (TTM) | 43.30M |
|---|---|
| Net Income (TTM) | -71.56M |
| Free Cash Flow (TTM) | -42.60M |
| EPS (TTM) | −$26.89 |
| Profit Margin | -165.24% |
| Operating Margin | -133.42% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 60.17M |
|---|---|
| Shares Outstanding | 3.54M |
| Price to Sales (P/S) | 1.39 |
| Price to Book (P/B) | -40.09 |
| EV/EBITDA | -1.87 |
| 50-Day MA | $23.20 |
|---|---|
| 200-Day MA | $24.62 |
| 1-Year Change | −43.46% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Pelthos Therapeutics at a Glance
As of the Oct 23, 2026 close, Pelthos Therapeutics (PTHS) has a market capitalization of $60.17M. The stock trades at 1.4× sales. Over the trailing twelve months it lost $71.56M on revenue of $43.30M and burned $42.60M of free cash flow.
As of its latest reported balance sheet, it holds $24.56M in cash and securities against $73.11M of debt, a net debt position of $48.55M.
Pelthos Therapeutics does not currently pay a dividend.
The share price is down 43.5% over the past year. At $17.00 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $18.19 to $37.50, below its 200-day moving average of $24.62.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $51.17, 201.0% above the Oct 23, 2026 close.
Frequently Asked Questions About Pelthos Therapeutics
What is the current stock price for PTHS?
As of the Oct 23, 2026 close, PTHS stock trades at $17.00. The 52-week range is $18.19–$37.50, with a day range of $17.50–$19.49.
What is the P/E ratio for PTHS?
The P/E ratio (Price-to-Earnings) for PTHS is shown in the Key Statistics section. This valuation metric helps compare Pelthos Therapeutics Inc. to industry peers.
Does PTHS pay dividends?
Pelthos Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PTHS?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for PTHS is Buy. The average 12-month price target is $51.17, a 201.0% upside from the Oct 23, 2026 close of $17.00.
What is the market cap of PTHS?
As of the Oct 23, 2026 close, Pelthos Therapeutics's market capitalization is $60.2M, classifying it as a micro-cap company. Pelthos Therapeutics operates in the Healthcare sector within the Biotechnology industry.